Cancer Letters
Volume 230, Issue 1 , Pages 81-89 , 8 December 2005

Characterization of two new variants of human catechol O-methyltransferase in vitro

Received 8 November 2004 ,Revised 13 December 2004 ,Accepted 18 December 2004.

References 

  1. Axelrod J, Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem. 1958;233:702–705
  2. Barnea ER, Avigdor S. Coordinated induction of estrogen hydroxylase and catechol-O-methyl transferase by xenobiotics in first trimester human placental explants. J. Steroid Biochem. 1990;35:327–331
  3. Axelrod J. Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol. Rev. 1966;18:95–113
  4. Ball P, Knuppen R. Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol. Suppl. (Copenhagen). 1980;232:1–127
  5. Salminen M, Lundstrom K, Tilgmann C, Savolainen R, Kalkkinen N, Ulmanen I. Molecular cloning and characterization of rat liver catechol-O-methyltransferase. Gene. 1990;93:241–247
  6. Lundstrom K, Salminen M, Jalanko A, Savolainen R, Ulmanen I. Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol. 1991;10:181–189
  7. Lundstrom K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase. Biochim. Biophys. Acta. 1995;1251:1–10
  8. Cohn CK, Dunner DL, Axelrod J. Reduced catechol-O-methyltransferase activity in red blood cells of women with primary affective disorder. Science. 1970;170:1323–1324
  9. Weinshilboum RM, Raymond FA. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am. J. Hum. Genet. 1977;29:125–135
  10. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34:4202–4210
  11. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250
  12. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, et al. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol. Biomarkers Prev. 2001;10:209–216
  13. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 1997;57:5493–5497
  14. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc. Natl Acad. Sci. USA. 1997;94:4572–4575
  15. Kirov G, Murphy KC, Arranz MJ, Jones I, McCandles F, Kunugi H, et al. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol. Psychiatry. 1998;3:342–345
  16. Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol. Psychiatry. 2004;9:151–160
  17. Saito S, Iida A, Sekine A, Miura Y, Sakamoto T, Ogawa C, et al. Identification of 197 genetic variations in six human methyltranferase genes in the Japanese population. J. Hum. Genet. 2001;46:529–537
  18. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 1999;22:231–238
  19. Li Y, Yao J, Chang M, Nikolic D, Yu L, Yager JD, et al. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase. Chem. Res. Toxicol. 2004;17:512–520
  20. Goodman JE, Jensen LT, He P, Yager JD. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics. 2002;12:517–528
  21. NIH Guidelines for the Laboratory Use of Chemical Carcinogens, US Government Printing Office, Washington, DC, 1981.
  22. Teuber HJ. Reactions with nitrosodisulfonate (III). Equilenin-quinone. Chem. Ber. 1953;86:1495–1499
  23. Han X, Liehr JG. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis. 1995;16:2571–2574
  24. Bolton JL, Pisha E, Shen L, Krol ES, Iverson SL, Huang Z, et al. The reactivity of o-quinones which do not isomerize to quinone methides correlates with alkylcatechol-induced toxicity in human melanoma cells. Chem. Biol. Interact. 1997;106:133–148
  25. Spink DC, Zhang F, Hussain MM, Katz BH, Liu X, Hilker DR, et al. Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells. Chem. Res. Toxicol. 2001;14:572–581
  26. Rao PN, Somawardhana CW. Synthesis of 2-methoxy and 4-methoxy equine estrogens. Steroids. 1987;49:419–432
  27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254
  28. Yao J, Li Y, Chang M, Wu H, Yang X, Goodman JE, et al. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase. Chem. Res. Toxicol. 2003;16:668–675
  29. Kitz R, Wilson IB. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J. Biol. Chem. 1962;237:3245–3249
  30. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res. 2001;61:6716–6722
  31. Scanlon PD, Raymond FA, Weinshilboum RM. Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science. 1979;203:63–65
  32. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001;10:635–640
  33. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res. 1998;58:2107–2110
  34. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res. 1997;69:71–77
  35. Sullivan AE, Goodman JE, Silber PM, Yager JD. Catechol-O-methyltransferase low activity genotype (COMTLL) is associated with low levels of COMT protein in human hepatocytes. Cancer Lett. 2004;214:189–195

PII: S0304-3835(04)01000-6

doi: 10.1016/j.canlet.2004.12.022

Cancer Letters
Volume 230, Issue 1 , Pages 81-89 , 8 December 2005

Article Tools

* Image Usage & Resolution